The FDA issued an emergency use authorization allowing healthcare providers to administer less of the monkeypox vaccine amid an escalating outbreak in the U.S. that is outstripping supply. In a press briefing at the White House, the FDA commissioner acknowledged the spread of monkeypox has outpaced vaccine supply and said the new dosing method — intradermally rather than subcutaneously — will multiply the total number of available doses by up to five.
FDA Vaccines Monkeypox

Related Timelines

This topic is part of 2 timelines. Explore the complete timeline to see this item in a broader context.

  1. FDA News and Announcements
  2. Monkeypox Outbreak

Just the Facts

Facteroid items are consise and factual. No editorializing, commentary, or clickbait.

Site design, logos, and content © 2021 Facteroid unless specified otherwise. Individual news and data pages may be licensed differently as specified on those pages.